Last week was noteworthy for hospitals: we may look back in months ahead and note the confluence of four announcements as the beginning of a consequential shift in U.S. health…
Read More
Theranos was touted as a high-flying disruptor in the $75 billion U.S. blood testing market dominated by incumbents like Abbott, Quest Diagnostics, LabCorp, Roche, Thermo-Fisher, Becton Dickinson and other big…
The latest Wall Street Journal NBC News poll predicts healthcare will be the number one issue in the mid-term elections this November, ranking above the economy, trade and immigration. Judging…
The biggest risk facing most healthcare organizations is not their financial sustainability nor uncertainty about the competitive environment: it’s inadequate attention to their ethical risks. It’s a costly oversight. Left…
